Findings from a new report published in the Journal of Clinical Oncology suggest that Erbitux (cetuximab) in combination with chemotherapy provides pretreated, unresectable patients who have liver metastases with the possibility of cure for their metastatic colorectal cancer (mCRC). [click link for full article]
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment